Literature DB >> 1320980

Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.

M J Sumner1, W Feniuk, J D McCormick, P P Humphrey.   

Abstract

1. We have investigated the mechanism of smooth muscle contraction evoked by activation of 5-HT1-like receptors in dog isolated saphenous vein. 2. In the presence of the 5-HT2 receptor antagonist, ritanserin (0.1 microM), concentration-effect curves (10 nM-300 microM) for 5-hydroxytryptamine (5-HT)-induced smooth muscle contraction were biphasic. This could be attributed to a direct action on 5-HT1-like receptors at low concentrations of 5-HT (10 nM-10 microM) and an indirect (through the release of noradrenaline from sympathetic neurones) activation of postjunctional alpha-adrenoceptors at higher 5-HT concentrations. In contrast, concentration-effect curves (100 nM-100 microM) for sumatriptan-induced contractions were not biphasic, and were due solely to activation of 5-HT1-like receptors. 3. Smooth muscle contractions evoked either by low concentrations of 5-HT or by sumatriptan were abolished by removal of extracellular calcium and were markedly inhibited, but not abolished, by the calcium channel blocker, verapamil (1-30 microM). In contrast, contractions evoked by high concentrations of 5-HT were markedly less sensitive to removal of extracellular calcium or to verapamil. 4. 5-HT and sumatriptan also inhibited (to a maximum of about 50%) prostaglandin E2 (PGE2, 5 microM)-stimulated adenosine 3':5'-cyclic monophosphate (cyclic AMP) formation. This effect was mimicked by the alpha 2-adrenoceptor agonist, azepexole (B-HT933) but not by the alpha 1-adrenoceptor agonist, methoxamine.5. In contrast to mediation of smooth muscle contraction, the 5-HT1-like receptor-mediated inhibition of PGE2-stimulated cyclic AMP formation evoked by 5-HT or sumatriptan was not attenuated by removal of extracellular calcium or by verapamil (1 microM).6. A directly-acting inhibitor of adenylyl cyclase, 2',3'-dideoxyadenosine (1 mM) inhibited PGE2-stimulated cyclic AMP formation but did not produce smooth muscle contraction.7. These results suggest that contractile responses of dog isolated saphenous vein arising through activation of 5-HT1-like receptors are associated with both an influx of extracellular calcium ions (to a large extent via voltage-dependent channels) and an inhibition of adenylyl cyclase. However, although these two responses are coupled to the same receptor, they appear to be independent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320980      PMCID: PMC1908450          DOI: 10.1111/j.1476-5381.1992.tb09026.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors.

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

Review 2.  The pharmacology of alpha 1- and alpha 2-adrenoceptors: evidence for and against a further subdivision.

Authors:  J R Docherty
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

3.  Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.

Authors:  R J Haslam; M M Davidson; J V Desjardins
Journal:  Biochem J       Date:  1978-10-15       Impact factor: 3.857

4.  The effects of alpha-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein.

Authors:  P P Humphrey
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

5.  Relationship between alpha 2-adrenoceptor occupancy and response for B-HT 933 in canine saphenous vein.

Authors:  R R Ruffolo; R L Zeid
Journal:  Eur J Pharmacol       Date:  1985-05-08       Impact factor: 4.432

6.  Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature.

Authors:  E Apperley; W Feniuk; P P Humphrey; G P Levy
Journal:  Br J Pharmacol       Date:  1980-02       Impact factor: 8.739

7.  Sumatriptan (GR43175) inhibits cyclic-AMP accumulation in dog isolated saphenous vein.

Authors:  M J Sumner; P P Humphrey
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

8.  Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.

Authors:  M J Perren; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

9.  Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava.

Authors:  M J Sumner; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

10.  GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.

Authors:  P P Humphrey; W Feniuk; M J Perren; H E Connor; A W Oxford; L H Coates; D Butina
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

View more
  11 in total

1.  The involvement of intracellular Ca(2+) in 5-HT(1B/1D) receptor-mediated contraction of the rabbit isolated renal artery.

Authors:  P B Hill; K A Dora; A D Hughes; C J Garland
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

2.  Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.

Authors:  H Giles; S J Lansdell; M L Bolofo; H L Wilson; G R Martin
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  The effect of forskolin on 5-HT1-like and angiotensin II-induced vasoconstriction and cyclic AMP content of the rabbit isolated femoral artery.

Authors:  V A Randall; S J MacLennan; G R Martin; V G Wilson
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  Involvement of 5-HT1B and 5-HT1D receptors in sumatriptan mediated vasocontractile response in rabbit common carotid artery.

Authors:  Demet Akin; Hakan Gurdal
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

5.  Alpha 2-adrenoceptor mediated inhibition of forskolin-stimulated cyclic AMP accumulation in isolated porcine palmar lateral veins.

Authors:  I K Wright; D A Kendall; V G Wilson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

6.  Examination of the role of inhibition of cyclic AMP in alpha 2-adrenoceptor mediated contractions of the porcine isolated palmar lateral vein.

Authors:  I K Wright; R Harling; D A Kendall; V G Wilson
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

7.  Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.

Authors:  T M Cocks; B K Kemp; D Pruneau; J A Angus
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

8.  A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-462 on human coronary artery in vitro.

Authors:  A Ferro; J Longmore; R G Hill; M J Brown
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

9.  Effects of 6-hydroxydopamine on pre- and post-junctional 5-HT1-like receptor-mediated responses in dog saphenous vein.

Authors:  A D Medhurst; G E Novotny; S G Parker; N M Deighton; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

10.  Importance of inositol (1,4,5)-trisphosphate, intracellular Ca2+ release and myofilament Ca2+ sensitization in 5-hydroxytryptamine-evoked contraction of rabbit mesenteric artery.

Authors:  J M Seager; T V Murphy; C J Garland
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.